The history of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, yielding billions in income, its intellectual property lapse created a deluge of generic competition , significantly eroding its market share . While some firms may try to capitalize on related treatments , the curr